189 related articles for article (PubMed ID: 35460926)
1. Prognosis of chronic kidney disease in patients with non-alcoholic fatty liver disease: a Northeastern Taiwan community medicine research cohort.
Huang TS; Wu IW; Lin CL; Shyu YC; Chen YC; Chien RN
Biomed J; 2023 Apr; 46(2):100532. PubMed ID: 35460926
[TBL] [Abstract][Full Text] [Related]
2. Fibrosis Risk in Nonalcoholic Fatty Liver Disease Is Related to Chronic Kidney Disease in Older Type 2 Diabetes Patients.
Sun Y; Hong L; Huang Z; Wang L; Xiong Y; Zong S; Zhang R; Liu J; Zang S
J Clin Endocrinol Metab; 2022 Aug; 107(9):e3661-e3669. PubMed ID: 35766414
[TBL] [Abstract][Full Text] [Related]
3. The impact of non-alcoholic fatty liver disease and liver fibrosis on adverse clinical outcomes and mortality in patients with chronic kidney disease: a prospective cohort study using the UK Biobank.
Hydes TJ; Kennedy OJ; Buchanan R; Cuthbertson DJ; Parkes J; Fraser SDS; Roderick P
BMC Med; 2023 May; 21(1):185. PubMed ID: 37198624
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive fibrosis assessments of non-alcoholic fatty liver disease associated with low estimated glomerular filtration rate among CKD patients: the Fukuoka Kidney disease Registry Study.
Hara M; Tanaka S; Torisu K; Matsukuma Y; Tsuchimoto A; Tokumoto M; Ooboshi H; Nakano T; Tsuruya K; Kitazono T
Clin Exp Nephrol; 2021 Aug; 25(8):822-834. PubMed ID: 33856608
[TBL] [Abstract][Full Text] [Related]
5. New Nonalcoholic Fatty Liver Disease and Fibrosis Progression Associate With the Risk of Incident Chronic Kidney Disease.
Zuo G; Xuan L; Xin Z; Xu Y; Lu J; Chen Y; Dai M; Zhang D; Wang W; Li M; Bi Y; Ning G; Xu M
J Clin Endocrinol Metab; 2021 Sep; 106(10):e3957-e3968. PubMed ID: 34125886
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver in USA.
Wijarnpreecha K; Thongprayoon C; Scribani M; Ungprasert P; Cheungpasitporn W
Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):404-410. PubMed ID: 29215435
[TBL] [Abstract][Full Text] [Related]
7. Advanced Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease.
Seo DH; Suh YJ; Cho Y; Ahn SH; Seo S; Hong S; Lee YH; Choi YJ; Lee E; Kim SH
Diabetes Metab J; 2022 Jul; 46(4):630-639. PubMed ID: 35081304
[TBL] [Abstract][Full Text] [Related]
8. High FIB-4 index as an independent risk factor of prevalent chronic kidney disease in patients with nonalcoholic fatty liver disease.
Xu HW; Hsu YC; Chang CH; Wei KL; Lin CL
Hepatol Int; 2016 Mar; 10(2):340-6. PubMed ID: 26676626
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive fibrosis scoring systems can predict future metabolic complications and overall mortality in non-alcoholic fatty liver disease (NAFLD).
Önnerhag K; Hartman H; Nilsson PM; Lindgren S
Scand J Gastroenterol; 2019 Mar; 54(3):328-334. PubMed ID: 30907181
[No Abstract] [Full Text] [Related]
10. Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: A cohort study.
Sinn DH; Kang D; Jang HR; Gu S; Cho SJ; Paik SW; Ryu S; Chang Y; Lazo M; Guallar E; Cho J; Gwak GY
J Hepatol; 2017 Dec; 67(6):1274-1280. PubMed ID: 28870674
[TBL] [Abstract][Full Text] [Related]
11. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.
Chinnadurai R; Ritchie J; Green D; Kalra PA
Nephrol Dial Transplant; 2019 Mar; 34(3):449-457. PubMed ID: 29390103
[TBL] [Abstract][Full Text] [Related]
12. Higher NAFLD fibrosis score is associated with impaired eGFR.
Hsieh MH; Wu KT; Chen YY; Yang JF; Lin WY; Chang NC; Lin CY; Huang CK; Wang CL; Chuang HY; Lin SC; Hsu YK; Tsai YS; Chuang WL; Yu ML; Dai CY
J Formos Med Assoc; 2020 Jan; 119(1 Pt 3):496-503. PubMed ID: 31353118
[TBL] [Abstract][Full Text] [Related]
13. Association between noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver disease.
Sesti G; Fiorentino TV; Arturi F; Perticone M; Sciacqua A; Perticone F
PLoS One; 2014; 9(2):e88569. PubMed ID: 24520400
[TBL] [Abstract][Full Text] [Related]
14. The liver-kidney axis: Is serum leptin a potential link in non-alcoholic fatty liver disease-associated chronic kidney disease?
Canbakan M; Bakkaloglu OK; Atay K; Koroglu E; Tuncer MM; Canbakan B; Senturk H
Arab J Gastroenterol; 2023 Feb; 24(1):52-57. PubMed ID: 36764893
[TBL] [Abstract][Full Text] [Related]
15. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
[TBL] [Abstract][Full Text] [Related]
16. Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis.
Musso G; Gambino R; Tabibian JH; Ekstedt M; Kechagias S; Hamaguchi M; Hultcrantz R; Hagström H; Yoon SK; Charatcharoenwitthaya P; George J; Barrera F; Hafliðadóttir S; Björnsson ES; Armstrong MJ; Hopkins LJ; Gao X; Francque S; Verrijken A; Yilmaz Y; Lindor KD; Charlton M; Haring R; Lerch MM; Rettig R; Völzke H; Ryu S; Li G; Wong LL; Machado M; Cortez-Pinto H; Yasui K; Cassader M
PLoS Med; 2014 Jul; 11(7):e1001680. PubMed ID: 25050550
[TBL] [Abstract][Full Text] [Related]
17. Utility of non-invasive liver fibrosis markers to predict the incidence of chronic kidney disease (CKD): A systematic review, meta-analysis, and meta-regression.
Supriyadi R; Yanto TA; Hariyanto TI; Suastika K
Diabetes Metab Syndr; 2023 Aug; 17(8):102814. PubMed ID: 37354810
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis.
Mantovani A; Zaza G; Byrne CD; Lonardo A; Zoppini G; Bonora E; Targher G
Metabolism; 2018 Feb; 79():64-76. PubMed ID: 29137912
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and risk factors for impaired renal function among Asian patients with nonalcoholic fatty liver disease.
Sun C; Goh GB; Chow WC; Chan WK; Wong GL; Seto WK; Huang YH; Lin HC; Lee IC; Lee HW; Kim SU; Wong VW; Fan JG
Hepatobiliary Pancreat Dis Int; 2024 Jun; 23(3):241-248. PubMed ID: 37620227
[TBL] [Abstract][Full Text] [Related]
20. Advanced liver fibrosis and the metabolic syndrome in a primary care setting.
Schreiner AD; Zhang J; Durkalski-Mauldin V; Livingston S; Marsden J; Bian J; Mauldin PD; Moran WP; Rockey DC
Diabetes Metab Res Rev; 2021 Nov; 37(8):e3452. PubMed ID: 33759300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
